Provided by Tiger Trade Technology Pte. Ltd.

Halozyme Therapeutics

105.35
-1.5700-1.47%
Pre-market: 104.47-0.8767-0.83%08:54 EDT
Volume:1.68M
Turnover:177.11M
Market Cap:11.96B
PE:31.15
High:106.81
Open:106.45
Low:104.70
Close:106.92
52wk High:109.66
52wk Low:61.23
Shares:113.50M
Float Shares:112.00M
Volume Ratio:1.06
T/O Rate:1.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.38
EPS(LYR):2.56
ROE:173.67%
ROA:25.49%
PB:83.30
PE(LYR):41.15

Loading ...

Aug 18, 2026

Major Issues Report

Form 8-K - Current report
Aug 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 02, 2026

Major Issues Report

Form 8-K - Current report
Jun 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Apr 24, 2026

Major Issues Report

Form 8-K - Current report
Mar 12, 2026

Major Issues Report

Form 8-K - Current report
Mar 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities